New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 11, 2014
16:34 EDTRCPIRock Creek Pharmaceuticals provides update on U.S. investigational NDA
Rock Creek Pharmaceuticals announced that the FDA has notified the company that the agency will provide comments on RCP's Investigational New Drug application before granting the company permission to start its clinical trial in the US. Dr. Chris Chapman, RCP's President, commented, "We appreciate the agency's review and comments on our IND. When we receive the agency's official comments and/or recommendations, we will respond expeditiously. We look forward to moving this important product through the regulatory process."
News For RCPI From The Last 14 Days
Check below for free stories on RCPI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RCPI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use